COO - CooperCompanies Book Valuation of Business

The Cooper Companies (COO) possesses minimal geopolitical risks due to the humanitarian status of its products and a flexible distribution system. This price chart illustrates the dynamics of an asset whose profits are based on the production of lenses and reproductive medicine tools, with the current indicator standing at 8.35. Stability of supply is ensured by the ownership of proprietary automated plants in Europe and the US with strict internal controls.

COO CooperCompanies Book Capitalization (07/04/2022 - 10/28/2026)

CooperCompanies (COO) - metric breakdowns and financial figures

- price and consensus price forecast:

Market Price CooperSurgical|COO - Price Target Chart

- market capitalization data:

Market Capitalization The Cooper Companies, Inc.|COO - Total Company Value

- book capitalization data:

Share Book Value CooperCompanies|COO - Book Capitalization|Market-to-Book Ratio coopercos.com|COO - Company Total Assets

- debt and liquidity data:

Total Debt to Equity Ratio The Cooper Companies|COO - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient The Cooper Companies, Inc.|COO - Company Aggregate Debts|Debts to Book Capitalization The Cooper Companies, Inc.

Fundamental company valuation:CooperSurgical - COO

Book value capitalization reflects the actual volume of The Cooper Companies (COO) equity, excluding subjective market valuations. This metric is calculated as the difference between total assets and liabilities, capturing the actual value of net assets. By analyzing the current book capital of The Cooper Companies (COO), an investor can observe the dynamics of internal financing. Growth in this metric is supported by the ownership of its own plants to ensure lens quality control. Moderate reliance on external IT contractors stabilizes the asset structure.

Competitor analysis